Jiyeon Seo
Pulmonary Disease · Los Angeles, CANPI 1740670504
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,481 of the $6,233 with a category attached, or 71.9%. Inspire Medical Systems, Inc. accounts for 70.5% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2024 at $3,188 and has fallen 55.7% since, to $1,413 in 2025.
Across 59 payments — averaging $105.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$4K
- Itamar Medical Inc$409
- Jazz Pharmaceuticals Inc.$277
- Boehringer Ingelheim$250
- Inari Medical, Inc.$190
- Penumbra, Inc.$130
- plus $582 from 7 others
What the payments were for
- Travel & lodging$1,68227%
- Food & beverage$4,48172%
- Education$701%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 41 | $4,396 |
| Itamar Medical Inc | 3 | $409 |
| Jazz Pharmaceuticals Inc. | 3 | $277 |
| Boehringer Ingelheim | 2 | $250 |
| Inari Medical, Inc. | 1 | $190 |
| Penumbra, Inc. | 1 | $130 |
| La Jolla Pharmaceutical Company | 1 | $113 |
| Vapotherm Inc | 2 | $112 |
| Edwards Lifesciences | 1 | $104 |
| ZOLL Respicardia, Inc. | 1 | $103 |
| Fisher & Paykel Healthcare Inc | 1 | $101 |
| Nabriva Therapeutics, PLC | 1 | $25 |
| Boston Scientific | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Inspire$3,378
- FISHER & PAYKEL HEALTHCARE$507
- WatchPATONE$301
- OFEV$250
- FLOWTRIEVER CATHETER, S$190
- CT THROMBECTOMY SYSTEM KIT$190
- Indigo System$130
- XYWAV$119
- GIAPREZA$113
- WatchPat$108
- remede System$103
How this compares
$6,233 in reported general payments places this provider in the 75th percentile of 1,261 pulmonary disease providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Los Angeles
- Toby MaherLos Angeles$1.3M
- Victor TapsonLos Angeles$514K
- Rajan SaggarLos Angeles$480K
- Igor BarjaktarevicLos Angeles$337K
- Scott OhLos Angeles$252K
- Christopher CooperLos Angeles$239K
- John BelperioLos Angeles$224K
- Robert StrieterLos Angeles$173K
- Roy ArtalLos Angeles$152K
- Donald TashkinLos Angeles$141K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.